NMI is an important component of a transcription factor complex that allows for the continuous activation of telomerase in breast and ovarian cancer, and participates in the regulation of bradykinin BDKRB2 and MAPK/ERK pathways, thus mediating tumor progression and metastasis18. The gene discussed is NMI; the disease is neoplasm.